Erik C. Emerson - 04 Mar 2025 Form 3 Insider Report for Apimeds Pharmaceuticals US, Inc. (APUS)

Signature
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
Issuer symbol
APUS
Transactions as of
04 Mar 2025
Transactions value $
$0
Form type
3
Filing time
08 May 2025, 16:54:24 UTC
Previous filing
18 Jan 2024
Next filing
20 May 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Emerson Erik C. Chief Executive Officer, Director C/O APIMEDS PHARMACEUTICALS US, INC., 2 EAST BROAD STREET, 2ND FLOOR, HOPEWELL /s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact 08 May 2025 0001710496

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney